Vitamin D blood testing can be confusing because “vitamin D” can mean different things depending on the lab order. In everyday practice, the vitamin D test most people need is 25-hydroxy vitamin D, also called 25(OH)D or calcidiol. It reflects the body’s vitamin D supply from sunlight, food, and supplements. The 1,25-dihydroxy vitamin D test, also called 1,25(OH)₂D or calcitriol, measures the active hormone form. It is not the best test for routine vitamin D deficiency because the body can keep calcitriol normal, or even high, while vitamin D stores are low. Instead, 1,25-dihydroxy vitamin D is mainly useful in specific settings, such as kidney disease, unexplained high calcium, certain granulomatous diseases, rare inherited vitamin D disorders, and some complex bone-mineral problems. Understanding which test was ordered prevents a common mistake: assuming a normal calcitriol level rules out low vitamin D stores.
- 25-hydroxy vitamin D is the usual blood test for vitamin D stores and deficiency.
- 1,25-dihydroxy vitamin D measures calcitriol, the active hormone form, not total vitamin D reserves.
- Low 25-hydroxy vitamin D can occur while 1,25-dihydroxy vitamin D is normal or high.
- 1,25-dihydroxy vitamin D is most useful with kidney disease, abnormal calcium, low PTH, granulomatous disease, or rare rickets patterns.
- Vitamin D toxicity is usually judged with 25-hydroxy vitamin D plus calcium, not with 1,25-dihydroxy vitamin D alone.
Table of Contents
- What the Two Vitamin D Blood Tests Measure
- Why 25-Hydroxy Vitamin D Is Checked First
- When 1,25-Dihydroxy Vitamin D Is Useful
- How Results Can Disagree
- Ranges, Units, and Result Patterns
- Common Mistakes When Reading Vitamin D Labs
- How to Follow Up on Abnormal Results
What the Two Vitamin D Blood Tests Measure
Vitamin D moves through several forms before it can do its main hormone-like work. The body can make vitamin D3 in the skin after ultraviolet B light exposure, and it can also absorb vitamin D2 or D3 from food and supplements. Those forms are not yet fully active. First, the liver converts vitamin D into 25-hydroxy vitamin D. Then the kidneys, and some other tissues, convert part of that supply into 1,25-dihydroxy vitamin D.
The confusing part is that both tests contain the words “vitamin D,” but they answer different clinical questions.
A 25-hydroxy vitamin D test estimates the body’s vitamin D reserve. It is the storage and transport form that rises or falls with sun exposure, diet, malabsorption, liver conversion, supplement intake, and long-term body stores. When clinicians screen for deficiency, monitor replacement, or evaluate possible toxicity from supplements, this is usually the test they mean.
A 1,25-dihydroxy vitamin D test measures calcitriol, the active hormone form. Calcitriol helps regulate calcium and phosphorus by increasing intestinal calcium absorption, influencing bone turnover, and feeding back on parathyroid hormone, often abbreviated PTH. Its blood level is tightly controlled and can change because of PTH, calcium, phosphorus, kidney function, fibroblast growth factor 23, inflammation, or abnormal immune-cell activation.
| Feature | 25-hydroxy vitamin D | 1,25-dihydroxy vitamin D |
|---|---|---|
| Common abbreviation | 25(OH)D | 1,25(OH)₂D |
| Common name | Calcidiol | Calcitriol |
| Main meaning | Vitamin D supply or stores | Active vitamin D hormone activity |
| Usual reason for ordering | Deficiency, replacement monitoring, toxicity evaluation | Kidney disease, abnormal calcium, granulomatous disease, rare rickets patterns |
| Controlled mostly by | Vitamin D intake, sun exposure, absorption, liver conversion, body stores | PTH, calcium, phosphorus, kidney activation, inflammatory or malignant cell activation |
| Best routine deficiency test? | Yes | No |
A simple way to remember the difference is this: 25-hydroxy vitamin D shows the available supply; 1,25-dihydroxy vitamin D shows a tightly regulated hormone output. A person can have a low supply but a normal hormone output for a while because the body increases PTH and pushes the kidneys to make more calcitriol.
Why 25-Hydroxy Vitamin D Is Checked First
25-hydroxy vitamin D is usually checked first because it best reflects vitamin D exposure from all major sources. It has a longer circulating half-life than calcitriol, so it gives a more stable picture of vitamin D status over time. It also changes in the expected direction when vitamin D intake, absorption, or sun exposure changes.
This is why 25(OH)D is used for most everyday vitamin D questions, including:
- Is vitamin D deficiency likely?
- Is replacement therapy raising vitamin D stores?
- Is a person taking too much vitamin D?
- Could low vitamin D be contributing to rickets, osteomalacia, secondary hyperparathyroidism, low calcium, or bone-mineral problems?
- Is a patient with malabsorption, bariatric surgery, chronic liver disease, certain medications, or limited sun exposure at risk?
Many people first encounter vitamin D testing after fatigue, bone aches, muscle symptoms, low calcium, osteoporosis evaluation, a history of low-trauma fracture, or routine health screening. A low result should not be interpreted alone. It makes more sense when viewed with calcium, phosphorus, alkaline phosphatase, kidney function, and PTH. For example, low 25(OH)D with high PTH can suggest secondary hyperparathyroidism, where the parathyroid glands are working harder to maintain calcium balance.
Vitamin D status is closely tied to calcium physiology, so a related vitamin D and calcium pattern can be more informative than either result alone. A normal calcium level does not rule out vitamin D deficiency, because PTH can keep blood calcium in range by increasing kidney activation of vitamin D and changing calcium handling in bone and kidneys.
Reference thresholds vary by laboratory and guideline. A common public-health framework considers 25(OH)D below 12 ng/mL as associated with deficiency risk, 12 to less than 20 ng/mL as often inadequate for bone and overall health in otherwise healthy people, and 20 ng/mL or higher as adequate for most. Some labs use wider “optimal” ranges, such as 20 to 50 ng/mL. Some specialty practices use higher targets in selected patients, but higher is not always better. Levels above 50 to 60 ng/mL may raise concern in some contexts, and vitamin D toxicity is usually associated with much higher 25(OH)D levels, especially when calcium is high.
The word “normal” also needs care. A lab reference interval is not always the same as a treatment target. A target depends on age, bone health, kidney function, calcium intake, pregnancy status, medications, malabsorption, and whether the person is being treated for a diagnosed deficiency.
When 1,25-Dihydroxy Vitamin D Is Useful
1,25-dihydroxy vitamin D is not a routine screening test, but it can be very helpful when the clinical question is about vitamin D activation, calcium regulation, or abnormal hormone production.
The test is often considered when calcium is high and the cause is unclear. In a typical vitamin D supplement overdose, 25(OH)D is high and calcium may be high. In some granulomatous diseases, such as sarcoidosis, or in some lymphomas, immune or tumor cells can produce calcitriol outside the usual kidney-controlled pathway. This can cause high calcium with high or inappropriately normal 1,25(OH)₂D, often with a suppressed PTH. In that situation, measuring calcitriol can help explain why calcium is high.
A high calcium blood test is especially important to interpret with PTH. If calcium is high and PTH is also high or not suppressed, primary hyperparathyroidism becomes a leading possibility. If calcium is high and PTH is low, clinicians often consider non-PTH causes, including vitamin D toxicity, malignancy, granulomatous disease, medication effects, and other endocrine problems.
The 1,25(OH)₂D test can also be useful in chronic kidney disease. The kidneys normally perform much of the circulating activation of 25(OH)D into calcitriol. As kidney function declines, calcitriol production may fall, phosphorus may rise, PTH may increase, and bone-mineral balance can become more complicated. In that setting, a clinician may check 1,25(OH)₂D as part of a broader mineral-bone evaluation, not as a stand-alone vitamin D store test. A vitamin D and kidney function pattern may include creatinine, eGFR, calcium, phosphorus, PTH, alkaline phosphatase, and sometimes urine calcium or other tests.
Rare inherited disorders are another reason to measure calcitriol. Some people have problems with 1-alpha hydroxylase, the enzyme that activates vitamin D, or with the vitamin D receptor, where tissues do not respond normally to calcitriol. These conditions are uncommon, but they can cause rickets, osteomalacia, abnormal calcium and phosphorus results, and unusual PTH patterns.
The test may also be ordered when a person has suspected vitamin D-dependent rickets, unexplained low phosphorus with bone disease, unusual calcium-phosphorus patterns, or a complex endocrine evaluation where standard tests do not explain the findings.
How Results Can Disagree
The two vitamin D tests can point in different directions because the body regulates them differently. This is the main reason calcitriol can mislead people who are trying to understand ordinary vitamin D deficiency.
In early or moderate vitamin D deficiency, 25(OH)D falls because the body’s reserve is low. The parathyroid glands may respond by making more PTH. PTH signals the kidneys to increase conversion of 25(OH)D into 1,25(OH)₂D. As a result, 1,25(OH)₂D may remain normal or become high. That normal or high calcitriol does not mean vitamin D stores are healthy. It may mean the body is compensating.
In chronic kidney disease, the opposite can occur. A person may have low, normal, or corrected 25(OH)D, but reduced kidney activation can contribute to low 1,25(OH)₂D. Phosphorus retention and FGF23 can also suppress calcitriol production. This is why kidney-related mineral disorders need more than a vitamin D storage test.
In granulomatous disease or some cancers, 1,25(OH)₂D can rise because cells outside the kidneys produce it in an unregulated way. That can increase calcium absorption and cause hypercalcemia. In this pattern, 25(OH)D may be normal, low, or only mildly elevated, while calcitriol is high. Vitamin D supplements can worsen calcium problems in susceptible people, so this pattern needs clinician-guided care.
In vitamin D supplement toxicity, 25(OH)D is usually the more useful marker. Very high vitamin D intake can raise 25(OH)D and lead to high calcium, high urine calcium, kidney stones, kidney injury, nausea, constipation, confusion, weakness, or abnormal heart rhythm. Calcitriol may not be high, so a normal 1,25(OH)₂D result does not rule out vitamin D toxicity.
| Pattern | Possible meaning | Helpful follow-up labs |
|---|---|---|
| Low 25(OH)D, normal or high 1,25(OH)₂D | Vitamin D stores may be low while PTH-driven activation is compensating | Calcium, phosphorus, PTH, alkaline phosphatase, magnesium |
| Normal 25(OH)D, low 1,25(OH)₂D | Reduced activation may occur with kidney disease or low PTH | Creatinine, eGFR, phosphorus, PTH, calcium |
| Normal or low 25(OH)D, high 1,25(OH)₂D, high calcium, low PTH | Possible unregulated calcitriol production, such as granulomatous disease or lymphoma | PTH, PTHrP, phosphorus, kidney function, inflammatory or malignancy evaluation as appropriate |
| Very high 25(OH)D, high calcium | Possible vitamin D excess or toxicity, especially with high supplement intake | Calcium, urine calcium, creatinine/eGFR, phosphorus, PTH |
These patterns are not diagnoses by themselves. They are clues. The same lab pattern can have more than one cause, and the person’s symptoms, medications, supplement dose, kidney function, calcium intake, and medical history often decide the next step.
Ranges, Units, and Result Patterns
25-hydroxy vitamin D is usually reported in ng/mL in the United States and nmol/L in many other countries. To convert ng/mL to nmol/L, multiply by 2.5. A 25(OH)D level of 20 ng/mL is about 50 nmol/L.
Common 25(OH)D interpretation categories include:
- Below 12 ng/mL, or below 30 nmol/L: associated with vitamin D deficiency risk and, when severe or prolonged, rickets in children or osteomalacia in adults.
- 12 to less than 20 ng/mL, or 30 to less than 50 nmol/L: often considered inadequate for bone and overall health in otherwise healthy people.
- 20 ng/mL or higher, or 50 nmol/L or higher: generally adequate for most people.
- Above 50 to 60 ng/mL, or above 125 to 150 nmol/L: may be associated with potential adverse effects in some guidance, especially if calcium is high or intake is excessive.
- Above 150 ng/mL, or above 375 nmol/L: often seen in vitamin D toxicity, though symptoms and calcium results matter.
Some laboratories use different decision limits. For example, one lab may flag a level of 18 ng/mL as low, while another may call 20 to 50 ng/mL the preferred range. This difference does not always mean clinicians disagree about severe deficiency. Most concern centers around how to label mild insufficiency and what target is best for people without clear symptoms or bone disease.
1,25-dihydroxy vitamin D is often reported in pg/mL. Adult reference ranges are much lower in absolute numbers because calcitriol circulates in tiny amounts. Some laboratories list adult ranges roughly around 18 to 64 pg/mL for males and 18 to 78 pg/mL for females, while children may have higher ranges. Exact ranges depend on the lab and method, so the result should be read against the reference interval printed on that report.
The units are easy to mix up. A 25(OH)D value of 30 ng/mL and a 1,25(OH)₂D value of 30 pg/mL are not equivalent. They measure different molecules, in different concentration ranges, with different clinical meanings. A person should not compare the numbers directly.
Calcium and PTH often add the most context. If vitamin D stores are low, PTH may rise to defend blood calcium. If calcium is high, PTH helps separate parathyroid-driven from non-parathyroid causes. If PTH is very low with high calcium, clinicians usually look beyond ordinary primary hyperparathyroidism. A PTH blood test can be one of the most important companion tests when vitamin D and calcium results do not fit together.
Phosphorus and alkaline phosphatase also matter. Low phosphorus may suggest renal phosphate wasting, certain rickets patterns, or high PTH effects. High alkaline phosphatase can occur when bone turnover is increased, including rickets, osteomalacia, healing fractures, liver-bile duct conditions, and growth in children. Magnesium matters because low magnesium can impair PTH secretion or action and can make calcium problems harder to correct.
Common Mistakes When Reading Vitamin D Labs
The most common mistake is ordering or interpreting 1,25-dihydroxy vitamin D as if it were the standard vitamin D level. A normal calcitriol result does not prove vitamin D stores are normal. A high calcitriol result does not prove vitamin D stores are high. In many people with low 25(OH)D, calcitriol stays normal because the body is still able to activate enough hormone for short-term calcium balance.
Another mistake is treating a lab value without checking the clinical setting. A mildly low 25(OH)D in a healthy adult is different from the same result in someone with malabsorption, chronic kidney disease, osteoporosis, low-trauma fracture, anticonvulsant use, bariatric surgery, inflammatory bowel disease, severe liver disease, or symptoms of osteomalacia. The result needs to be interpreted with risk, symptoms, and related labs.
A third mistake is assuming more vitamin D is always safer or better. Vitamin D is fat-soluble, and high supplement doses can accumulate. Toxicity is uncommon, but when it happens, the main danger is high calcium. Symptoms can include nausea, vomiting, constipation, thirst, frequent urination, dehydration, confusion, weakness, kidney stones, and kidney injury. People taking high-dose vitamin D, calcitriol, calcium supplements, thiazide diuretics, or multiple supplement products should be especially careful.
A fourth mistake is ignoring calcium. Vitamin D results do not stand apart from calcium balance. A person with low vitamin D stores and normal calcium may still need treatment, but a person with high calcium needs a different kind of evaluation before adding vitamin D. In some causes of high calcitriol, extra vitamin D can worsen hypercalcemia.
A fifth mistake is forgetting assay variation. Vitamin D testing has improved, especially with liquid chromatography-tandem mass spectrometry methods, but different assays can still produce different values. If a result does not match the clinical picture, repeating the test, using the same lab for monitoring, or reviewing the assay method may help.
A sixth mistake is overlooking supplement details. “Vitamin D” on a label may be D2, D3, calcifediol, or an active vitamin D analog prescribed for kidney or parathyroid disease. Calcitriol is not the same as over-the-counter vitamin D3. Prescription active vitamin D forms can raise calcium more directly and require closer monitoring.
How to Follow Up on Abnormal Results
Follow-up starts with confirming which test was ordered. Look for 25-hydroxy vitamin D, 25(OH)D, calcidiol, or 25-OH vitamin D if the goal is to assess vitamin D stores. Look for 1,25-dihydroxy vitamin D, 1,25(OH)₂D, or calcitriol if the goal is to evaluate activation or unusual calcium-mineral patterns.
For low 25(OH)D, clinicians often review sunlight exposure, diet, supplement use, body weight, gastrointestinal absorption, liver disease, kidney disease, and medications. Common medication contributors include some antiseizure drugs, glucocorticoids, certain HIV medications, some antifungals, and drugs that affect fat absorption. The follow-up panel may include calcium, phosphorus, alkaline phosphatase, PTH, magnesium, creatinine, and eGFR.
For very low 25(OH)D with bone pain, muscle weakness, low calcium, low phosphorus, high alkaline phosphatase, or high PTH, evaluation should be more careful. Severe deficiency can cause osteomalacia in adults and rickets in children. Treatment may require higher replacement doses, attention to calcium intake, and monitoring to make sure the expected pattern improves.
For high 25(OH)D, the next question is whether calcium is high. A high vitamin D level with normal calcium may still need dose reduction and monitoring, depending on the number and the person’s risk factors. A high vitamin D level with high calcium deserves prompt medical review, especially if there are symptoms, kidney disease, kidney stones, dehydration, or confusion.
For high 1,25(OH)₂D, follow-up depends heavily on calcium and PTH. If calcium is normal and the person has no concerning symptoms, the result may be less urgent, but it still needs context. If calcium is high and PTH is low, clinicians may evaluate for granulomatous disease, lymphoma, vitamin D excess, PTHrP-related malignancy, or other less common causes.
For low 1,25(OH)₂D, kidney function and PTH are central. Low calcitriol may occur in chronic kidney disease or hypoparathyroidism. Treatment is not the same as ordinary vitamin D3 replacement in every case. Some people need nutritional vitamin D; others may need active vitamin D medication, phosphate management, calcium adjustment, or specialist care.
Bring the actual report to the appointment, not just the word “normal” or “low.” The report shows units, method, reference range, and whether the test was 25(OH)D or 1,25(OH)₂D. Also bring supplement labels and doses, including multivitamins, calcium products, cod liver oil, fortified nutrition shakes, prescription calcitriol, and any compounded products.
Urgent medical care is appropriate when abnormal vitamin D or calcium results come with severe weakness, confusion, dehydration, fainting, persistent vomiting, irregular heartbeat, severe constipation, new kidney problems, or very high calcium. These symptoms may come from hypercalcemia or another acute problem and should not be managed with supplements alone.
References
- Vitamin D – Health Professional Fact Sheet 2025 (Official Fact Sheet)
- Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline 2024 (Guideline)
- Vitamin D Deficiency in Adults: Screening 2021 (Recommendation Statement)
- 25-Hydroxyvitamin D2 and D3, Serum 2026 (Test Catalog)
- 1,25-Dihydroxyvitamin D, Serum 2026 (Test Catalog)
Disclaimer
Vitamin D and calcium-related blood tests should be interpreted with a qualified clinician, especially when calcium, kidney function, PTH, phosphorus, or symptoms are abnormal. Do not start high-dose vitamin D, calcitriol, or calcium supplements based only on one lab result unless your clinician has recommended that plan and monitoring.
